A prophylactic antibody-based immune therapy protects monkeys against severe disease caused by H5N1 avian flu, University of Pittsburgh and NIH Vaccine Research Center researchers report today in ...

Scientists found that a moderate dose of MEDI8852, an antibody therapy, effectively protected monkeys against severe H5N1 avian flu.

While the H5N1 bird flu keep spreading, the first reported H5N9 outbreak in the United States has been identified on a duck ...

Dairy cows build a natural immunity to H5N1 after initial infection according to research conducted at the University of ...